HanchorBio Inc. 漢康生技股份有限公司
HanchorBio Inc. (TWSE: 7827) is a global clinical-stage biotechnology company developing next-generation immunotherapies for oncology and immune-mediated diseases. Source (opens in a new tab)
- Website
- https://hanchorbio.com/
- Headquarters
- TW